Wells Fargo
LEGN icon

Wells Fargo’s Legend Biotech LEGN Stock Holding History

Wells Fargo’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$507K Sell
17,546
-5,010
-22% -$135K ﹤0.01% 4615
2026
Q1 		$408K Buy
22,556
+9,712
+76% +$185K ﹤0.01% 4278
2025
Q4 		$279K Sell
12,844
-2,702
-17% -$77.4K ﹤0.01% 4875
2025
Q3 		$507K Buy
15,546
+108
+0.7% +$3.99K ﹤0.01% 4292
2025
Q2 		$548K Buy
15,438
+42
+0.3% +$1.36K ﹤0.01% 4076
2025
Q1 		$522K Buy
15,396
+3,160
+26% +$113K ﹤0.01% 4064
2024
Q4 		$398K Sell
12,236
-2,703
-18% -$112K ﹤0.01% 4338
2024
Q3 		$728K Buy
14,939
+2,898
+24% +$154K ﹤0.01% 3753
2024
Q2 		$533K Sell
12,041
-3,010
-20% -$139K ﹤0.01% 3866
2024
Q1 		$844K Buy
15,051
+6,852
+84% +$413K ﹤0.01% 3563
2023
Q4 		$493K Buy
8,199
+2,022
+33% +$128K ﹤0.01% 3880
2023
Q3 		$415K Buy
6,177
+2,759
+81% +$192K ﹤0.01% 3894
2023
Q2 		$236K Buy
3,418
+3,397
+16,176% +$222K ﹤0.01% 4482
2023
Q1 		$1.01K Buy
21
+11
+110% +$538 ﹤0.01% 6373
2022
Q4 		$499 Hold
10
– – ﹤0.01% 6387
2022
Q3 		$0 Hold
10
– – ﹤0.01% 7040
2022
Q2 		$1K Hold
10
– – ﹤0.01% 6543
2022
Q1 		$0 Sell
10
-1,328
-99% -$52.5K ﹤0.01% 7474
2021
Q4 		$62K Buy
+1,338
New +$67.9K ﹤0.01% 5866
2020
Q4 		– Sell
-400
Closed -$12K – 6767
2020
Q3 		$12K Buy
+400
New +$13.5K ﹤0.01% 5857

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Wells Fargo's LEGN Position: Q2 2026 in Review

Wells Fargo reduced its Legend Biotech (LEGN) stake by 22% in Q2 2026, selling an estimated $135K and leaving 17,546 shares worth $507K. The position accounts for ﹤0.01% of the portfolio, ranked #4615.

Wells Fargo first reported a position in LEGN in Q3 2020 and has held it in 20 quarters since. The position peaked at $844K in Q1 2024. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Wells Fargo held 17,546 shares of Legend Biotech worth $507K as of Q2 2026.
  • Wells Fargo sold 5,010 Legend Biotech shares in Q2 2026, an estimated $135K.
  • Legend Biotech made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4615 holding.
  • Wells Fargo first reported a position in Legend Biotech in Q3 2020 and has held it in 20 quarters since.
  • Wells Fargo's Legend Biotech position peaked at $844K in Q1 2024.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.